Blacks Network | Social networking for everyone

2 yrs

A Decade of Diagnostics: Immunoassay Market Future 2022 To 2032

The Immunoassay Market is expected to observe growth at a CAGR of 5% and is anticipated to touch a valuation of USD 45.78 bn by 2032, while it holds a revenue of USD 29.51 Bn in 2022

The dynamic shift from the last forecast period (2017-2021) to the current forecast period (2022-2032) is significant. The major factors that have shaped the growth dynamics are the advent of covid-19, the geriatric population, and rising awareness around health

With the environment changing and climate change-based diseases and viruses growing in the urban and rural areas, the demand for vaccines is on a rise. The immunoassay market survey explains that the tests of the effectiveness of these vaccines are conducted through immunoassays tests that include the strength of antibodies in the immune system, fueling the sales of immunoassay testing kits.

Download a sample to obtain additional highlights and key points on various market segments and their impact in the coming years @
https://www.futuremarketinsigh....ts.com/reports/sampl

Rising awareness, government research and development programs, and covid-19’s spread has collectively flourished the demand for the antibodies testing systems. Hence, it has expanded the immunoassay market share in the global market

This fueled the market’s growth prospects and brought opportunities for the new medical and healthcare market players to come up with the latest technology and integrate it with immunoassay technology. Furthermore, the breakdown of the third covid-19 wave has partially slowed down the growth of the market as the spread is at lower levels

Key Takeaways from Market Study

The Immunoassay market is expected to increase with a market share of 35.0% in North America.
Asia Pacific is expected to account for 30% market share during the assessment year.
By product, reagents and kits accounted for 60% share of total revenue generated of the immunoassay market globally and is anticipated to hold the highest share by 2032, owing to the cost-effective products, fueling the overall sales of immunoassay testing instrument
EIA/ELISA technology gains the highest traction in the market by technology with a market share of 60% and its growth owing to higher use of it in reducing the assay time for immunoelectrophoretic and immunodiffusion while providing accurate and quantitive results.

Immunoassay Market in North America is Constantly Evolving

The largest market share of 35% in 2022 is expected to hold the same position throughout the forecast period, according to the Immunoassay Market Demand Analysis. The rise in demand can be attributed to an increase in cancer incidence as well as the ease of access to technologically advanced diagnostic techniques. Outbreaks of infectious diseases are becoming more common in the region.

Expand operations in the future – To get requisite details, ask for a custom report@
https://www.futuremarketinsigh....ts.com/customization

“Immunoassay market analysis displays the higher growth prospects due to the higher awareness of the new viruses and diseases that demand for higher antibodies in the body. An immunoassay test gives you information about the antibodies present in the body for any specific virus or disease spread by it. Demand for immunoassay tests rises as the hospitals, clinics, and research and development centers established by the government are consuming the most from the market” says a Future Market Insights analyst.

Competitive Landscape

New market research report on immunoassay defines the market space as a younger space where there is a space for innovation and technology. The defining factors key players have been the ability to deliver effective and accurate results while making the product more logistics friendly and easy to use.

Siemens Healthineers has introduced its latest and revised fully automated immunoassay platforms and a comprehensive and disease-specific chart in excess of 100 tests. This enhanced productivity and efficiency while delivering accurate and faster results.
Biomerieux, with more than 26000 immunoassay systems globally has introduced its R7D programs that covers high medical value applications, increased automation and decentralized testing, flourishing the sales of immunoassay platforms.
Abbott Laboratories focuses on chia technology and offers an automatic immunoassay analyzer named Abbott prism, delivers effectiveness and enhances productivity.

Explore More Valuable Insights

Future Market Insights, in its new report, offers an impartial analysis of the global Immunoassay market, presenting historical data (2017-2021) and estimation statistics for the forecast period of 2022-2032.

The study offers compelling insights based on Application (Food, Beverage, Pharmaceuticals, Other (Applications), Form (Natural Immunoassay, Synthetic Immunoassay), Region (North America, Latin America, Europe, East Asia, South Asia, Oceania, MEA)

Buy Now to Gain Access to Detailed Information About Each Segment and Identify Key Trends, Drivers, and Challenges in the Market@ https://www.futuremarketinsigh....ts.com/checkout/1543

Immunoassay Market by Category

By Product, Immunoassay Market is segmented as:

Reagents & Kits
Analyzers/Instruments
Open-ended Systems
Closed-ended Systems
Software & Services

By Technology, Immunoassay Market is segmented as:

Radioimmunoassay (RIA)
Enzyme Immunoassays (EIA)Rapid Test
Chemiluminescence Immunoassays (CLIA)
Fluorescence Immunoassays (FIA)
Others

By End-use, Immunoassay Market is segmented as:

Therapeutic Drug Monitoring
Oncology
Cardiology
Endocrinology
Infectious Disease Testing
Autoimmune Diseases

By Application, Immunoassay Market is segmented as:

Hospitals
Blood Banks
Clinical Laboratories
Pharmaceutical and Biotech Companies
Academic Research Centers
Others

By Form, Immunoassay Market is segmented as:

Natural Immunoassay
Synthetic Immunoassay

Explore Wide-ranging Coverage of FMI’s Healthcare Landscape:

Amniotic Membranes Market: The global amniotic membranes market size is likely to touch a valuation of around US$ 1.4 Bn in 2022. Further, with rising adoption of amniotic membranes for various purposes in ophthalmology, the total sales of amniotic membranes are slated to grow at an impressive CAGR of 9.0% between 2022 and 2028, totalling over US$ 2.3 Bn by the end of 2028.

Digital Radiography Detectors Market: The digital radiography detectors market is valued at US$ 2.13 Bn in 2022. The market is advancing at an average pace with a CAGR of 6.1% through 2026 to reach a valuation of US$ 2.7 Bn. The worldwide market for digital radiography detectors is highly concentrated, with large competitors such as Varex Imaging Corporation and Trixell accounting for about 47% of the market share.

Sepsis Diagnostics Market: The global sepsis diagnostics market is expected to record a CAGR of 8.1% between 2023 and 2033. In 2023, the market is estimated to be valued at US$ 561.2 million. The valuation is expected to cross US$ 1.2 billion by 2033

Giống

Bình luận

Who is in your network?

Phát hiện bài viết

Exploring the Hunger Games District Map: Unveiling the Panem Universe – Article Bowl – Bloggers Unite India

Byte Bell - Millie Bobby Brown Net Worth:...